Tucidinostat

Tucidinostat.svg

Tucidinostat (also known as Chidamide) is a histone deacetylase inhibitor (HDACi) used in the treatment of various types of cancer. It is particularly noted for its application in the treatment of peripheral T-cell lymphoma (PTCL) and relapsed/refractory T-cell lymphoma.

Mechanism of Action

Tucidinostat works by inhibiting the activity of histone deacetylase enzymes. These enzymes are responsible for removing acetyl groups from histone proteins, leading to a more condensed chromatin structure and reduced gene expression. By inhibiting these enzymes, Tucidinostat causes an accumulation of acetylated histones, resulting in a more relaxed chromatin structure and increased expression of tumor suppressor genes. This can lead to the inhibition of cancer cell growth and induction of apoptosis.

Clinical Use

Tucidinostat has been approved for the treatment of peripheral T-cell lymphoma in several countries. It is often used in patients who have not responded to other treatments or have relapsed after initial therapy. Clinical trials have shown that Tucidinostat can be effective in inducing remission in a significant proportion of patients with PTCL.

Side Effects

Common side effects of Tucidinostat include fatigue, nausea, vomiting, and thrombocytopenia. More severe side effects can include neutropenia, anemia, and infections. Patients undergoing treatment with Tucidinostat require regular monitoring of blood counts and liver function tests.

Research and Development

Ongoing research is exploring the use of Tucidinostat in combination with other anticancer agents to enhance its efficacy. Studies are also investigating its potential application in other types of cancer, including breast cancer, lung cancer, and colorectal cancer.

See Also

• Histone deacetylase inhibitor
• Peripheral T-cell lymphoma
• Cancer treatment

External Links

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian